Bronchiolitis Obliterans Syndrome (BOS) Completed Phase 1 / 2 Trials for Etanercept (DB00005)

Also known as: Bronchiolitis Obliterans (BO) / Bronchiolitis Obliterans / Obliterative Bronchiolitis / Bronchiolitis Obliterans Syndrome / Obliterating fibrous bronchiolitis (disorder) / Bronchiolitis fibrosa obliterans (disorder) / Obliterative bronchiolitis (disorder)

IndicationStatusPhase
DBCOND0071683 (Bronchiolitis Obliterans Syndrome (BOS))Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00029328Etanercept for Non-Infectious Lung Injury Following Bone Marrow TransplantationTreatment